Windlas Biotech Limited (NSE:WINDLAS)
India · Delayed Price · Currency is INR 800.00
-22.80 (-2.77%)
May 11, 2026, 3:29 PM IST
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 17.37 billion as of May 11, 2026. Its market cap has decreased by -23.36% in one year.
Market Cap
17.37B
Enterprise Value
15.07B
Revenue
8.68B
Ranking
n/a
PE Ratio
26.17
Stock Price
800.00
Market Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 17.37B, an increase of 95.71%. That is a compound annual growth rate of 15.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 17.37B | 4.22% |
| Dec 31, 2025 | 16.66B | -23.42% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
| Aug 16, 2021 | 8.87B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 56.17B |
| Innova Captab | 50.11B |
| RPG Life Sciences | 40.74B |
| Orchid Pharma | 35.68B |
| Solara Active Pharma Sciences | 25.31B |
| Indoco Remedies | 21.04B |
| Jagsonpal Pharmaceuticals | 14.59B |
| Beta Drugs | 13.35B |